[N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-propylamine, a new synthetic substance for the treatment, from the etiopathogenic viewpoint, of myocardiopathies caused by coronary insufficiency].
Il Farmaco; edizione pratica
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
coronary artery insufficiency
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics